Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001666071-20-000263
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-18 16:13:04
Reporting Period:
2020-09-16
Accepted Time:
2020-09-18 16:13:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617486 D. Scott Grimes C/o Cardlytics, Inc.
675 Ponce De Leon Avenue Ne, Suite 6000
Atlanta GA 30308
Executive Chairman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-09-16 1,046 $72.18 114,066 No 4 S Indirect See Footnote
Common Stock Disposition 2020-09-16 800 $73.15 113,266 No 4 S Indirect See Footnote
Common Stock Disposition 2020-09-16 154 $74.05 113,112 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 235,790 Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
  2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $71.80 to $72.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4) and (5) to this Form 4.
  3. The Reporting Person is the trustee of the GRAT.
  4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $72.87 to $73.46, inclusive.
  5. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $73.92 to $74.30, inclusive.